Table 4.
Fever and parasite clearance in efficacy trials in Cameroon
| Study ID | Fever clearance (%) | Parasite clearance (%) | Supervised | ||||
|---|---|---|---|---|---|---|---|
| Day 1 | Day 2 | Day 3 | Day 2 | Day 3 | Day 7 | ||
| CMR001_ASSP | 25 | 50 | 90.9 | NR | 99 | 99 | Partial |
| CMR001_ASAQ | 25 | 50 | 92 | NR | 99 | 99 | Partial |
| CMR002_AL | 86 | 87.5 | 99.8 | 99.8 | 99.8 | 95 | Yes |
| CMR002_ASAQ | 90 | 96 | 99.8 | 99.1 | 99.8 | 95 | Yes |
| CMR002_DHPP | 90 | 95 | 99.8 | 99.1 | 99.8 | 90 | Yes |
| CMR003_ASAQ | 98.5 | 69 | 98.5 | 80.9 | 97.1 | NR | Yes |
| CMR003_ASATPG | 98 | 100 | 99 | 97.1 | 99 | NR | Yes |
| CMR004_ASAQ | 81 | 90 | 95 | 85 | 95 | 98 | Partial |
| CMR004_AL | 80 | 89.1 | 95 | 90 | 96 | 98 | Partial |
| CMR005a_ASAQ | 90 | 94.7 | 98.2 | 87.7 | 100 | 98.2 | Yes |
| CMR005a_ASSP | 81.90 | 98.2 | 100 | 89.7 | 96.6 | 100 | Yes |
| CMR005b_ASAQ | 92.10 | 98.3 | 98.3 | 87.9 | 98.3 | 100 | Yes |
| CMR005c_ASMQ | 86.8 | 96.9 | 98.3 | 86.2 | 95.3 | 100 | Yes |
| CMR005d_ASAQ | 93.1 | 95.1 | 98.3 | 96.6 | 98.3 | 100 | Yes |
| CMR005d_AL | 78.3 | 93.5 | 98.3 | 93.3 | 100 | 100 | Yes |
| CMR005e_ASCD | 84.9 | 97.6 | 100 | 95.1 | 100 | 100 | Yes |
| CMR005e_ASSP | 96.3 | 96.3 | 100 | 92.9 | 97.6 | 100 | Yes |
| CMR005f_ASAQ | 92.3 | 98.9 | 100 | 94.6 | 98.9 | 98.9 | Yes |
| CMR005f_DHPP | 92.3 | 96.7 | 92.3 | 94.5 | 100 | 100 | Yes |
| CMR006_ASMQ | NR | NR | NR | NR | NR | NR | Partial |
NR not reported